Quality Assurance
U.K. Stem Cell Bank role reviewed in providing access to human stem cell seed stock lines
Published in Blood Weekly, February 16th, 2006
"The rapidly expanding field of stem cell research offers the potential to develop therapeutic agents to treat diseases such as Parkinson, diabetes and heart disease," scientists in England report in their review.
"It is important that stem cell lines derived from quality-controlled and well-characterized cell banks should be made available to both the scientific and clinical communities to promote high-quality research and development. The requirement in the United Kingdom (U.K.) for rigorous regulation of the procurement...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2006-02-16)
More Articles from Blood Weekly
- Biomedical Engineering
Mild hypothermia preserves bioartificial liver loaded with freshly isolated liver cells - Blood Banking
Germ-free closed system developed for clinical banking of umbilical cord blood - Blood Transfusion
RhD typing for blood transfusion is not needed in southeast Asian populations - Cryopreservation
Trehalose improves cryopreservation of human embryonic stem cells - Tissue Engineering
Chondrocyte-seeded constructs better than unseeded carrier material for knee defect repair - Adult Stem Cells
Powerful technique for multiplying adult stem cells may aid therapies - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
